Dr. Lydia Scarfò is a physician scientist at the B-cell neoplasia Unit and an assistant professor at Università Vita-Salute San Raffaele, Milano, Italy.
June 27, 2025
Video
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
This Wasn't the Plan: The Truth
Living With Intention After a Cancer Diagnosis
June Lung Cancer Highlights: Top 5 Updates Patients Should Know
Could Shedding a Few Pounds Prevent a Breast Cancer Recurrence?